{"id":8976,"date":"2019-06-28T06:22:41","date_gmt":"2019-06-28T10:22:41","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=8976"},"modified":"2019-06-28T18:37:54","modified_gmt":"2019-06-28T22:37:54","slug":"new-filings-updated-terms-ending-6-28-19","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-ending-6-28-19\/","title":{"rendered":"New Filings &#038; Updated Terms (ending 6.28.19)"},"content":{"rendered":"<p>Here is a look at the new IPO filings &amp; Updated Terms over the last seven days. The full pipeline <a href=\"https:\/\/www.ipoboutique.com\/cgi\/initial-public-offering-pipeline.php\"><strong>can be found here<\/strong><\/a>.<\/p>\n<p><!--more--><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-28-at-6.25.09-AM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-medium wp-image-8980\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-28-at-6.25.09-AM-300x235.png\" alt=\"\" width=\"300\" height=\"235\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-28-at-6.25.09-AM-300x235.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-28-at-6.25.09-AM.png 470w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a> <a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-28-at-6.25.04-AM.png\"><img decoding=\"async\" class=\"alignnone size-medium wp-image-8981\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-28-at-6.25.04-AM-300x231.png\" alt=\"\" width=\"300\" height=\"231\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-28-at-6.25.04-AM-300x231.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2019\/06\/Screen-Shot-2019-06-28-at-6.25.04-AM.png 485w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><strong>NEW FILINGS<\/strong><\/p>\n<p>Company: ProSight Global, Inc.<br \/>\nSymbol: PROS<br \/>\nDescription: They are an entrepreneurial specialty insurance company that since our founding in 2009 has built products, services and solutions with the goal of significantly improving the experience and value proposition for our customers.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs, Barclays, BofA Merrill Lynch<br \/>\nCo-Manager(s): Dowling &amp; Partners, Keefe Bruyette &amp; Woods, SunTrust Robinson Humphrey, Citizens Capital Markets<br \/>\nFiled: 6-28-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Health Catalyst, Inc.<br \/>\nSymbol: HCAT<br \/>\nDescription: They are a leading provider of data and analytics technology and services to healthcare organizations.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs, JP Morgan, William Blair<br \/>\nCo-Manager(s): Piper Jaffray, Evercore ISI, SVB Leerink, SunTrust Robinson Humphrey<br \/>\nFiled: 6-27-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Sunnova Energy International Inc.<br \/>\nSymbol: NOVA<br \/>\nDescription: They are a leading residential solar and energy storage service provider, serving more than 63,000 customers in more than 20 U.S. states and territories.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): BofA Merrill Lynch, JP Morgan, Goldman Sachs, Credit Suisse<br \/>\nCo-Manager(s): KeyBanc Capital, Baird, Roth Capital<br \/>\nFiled: 6-27-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: WiMi Hologram Cloud, Inc.<br \/>\nSymbol: WIMI<br \/>\nDescription: They offer augmented reality (AR) based holographic services and products to cater to our customers&#8217; needs, all centered upon providing an innovative, immersive and interactive holographic augmented reality experience for our customers and end users.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Benchmark, Maxim, China Merchants Securities, AMTD Global Markets<br \/>\nCo-Manager(s): BOCI, Everbright Sun Hung Kai, GF Securities Brokerage, Axiom Capital Management<br \/>\nFiled: 6-27-19<br \/>\nListed Cash Raise: $50m<\/p>\n<p>Company: Castle Biosciences, Inc.<br \/>\nSymbol: CSTL<br \/>\nDescription: They are a commercial-stage dermatological cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): SVB Leerink, Baird<br \/>\nCo-Manager(s): Canaccord Genuity, BTIG<br \/>\nFiled: 6-26-19<br \/>\nListed Cash Raise: $57.5m<\/p>\n<p>Company: AssetMark Financial Holdings, Inc.<br \/>\nSymbol: AMK<br \/>\nDescription: AssetMark is a leading provider of extensive wealth management and technology solutions that power independent financial advisers and their clients.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): JP Morgan, Goldman Sachs, Credit Suisse, Huatai Securities<br \/>\nCo-Manager(s): BMO Capital, Raymond James, William Blair<br \/>\nFiled: 6-24-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Afya Limited<br \/>\nSymbol: AFYA<br \/>\nDescription: They are the leading medical education group in Brazil based on number of medical school seats, as published by the Brazilian Ministry of Education<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itau BBA, Morgan Stanley, BTG Pactual, XP Investments<br \/>\nFiled: 6-24-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Medallia, Inc.<br \/>\nSymbol: MDLA<br \/>\nDescription: They created a new category of enterprise software, experience management, and they are the market leader.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): BofA Merrill Lynch, Citigroup, Wells Fargo Securities Credit Suisse<br \/>\nCo-Manager(s): Oppenheimer, William Blair, Needham, Craig Hallum Capital Group, Roth Capital<br \/>\nFiled: 6-21-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Phreesia, Inc.<br \/>\nSymbol: PHR<br \/>\nDescription: They are a leading provider of comprehensive solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): JP Morgan, Wells Fargo Securities, William Blair, Allen &amp; Co., Piper Jaffray<br \/>\nFiled: 6-21-19<br \/>\nListed Cash Raise: $125m<\/p>\n<p>Company: Fulcrum Therapeutics, Inc.<br \/>\nSymbol: FULC<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, SVB Leerink<br \/>\nFiled: 6-21-19<br \/>\nListed Cash Raise: $86.25m<\/p>\n<p>Company: Mirum Pharmaceuticals, Inc.<br \/>\nSymbol: MIRM<br \/>\nDescription: They are a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Citigroup, Evercore ISI, Guggenheim Securities<br \/>\nCo-Manager(s): Raymond James, Roth Capital<br \/>\nFiled: 6-21-19<br \/>\nListed Cash Raise: $86.25m<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>TERMS ADDED<\/strong><\/span><\/p>\n<p>NONE AT THIS TIME<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Here is a look at the new IPO filings &amp; Updated Terms over the last seven days. The full pipeline can be found here.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-8976","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=8976"}],"version-history":[{"count":6,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8976\/revisions"}],"predecessor-version":[{"id":8991,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/8976\/revisions\/8991"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=8976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=8976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=8976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}